Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sintim Mui
Observed name:
Mui, Sintim
Institution:
First Affiliated Hospital of Guangzhou Medical University
Observed institutions:
Sun Yat-sen University,
Sun Yat-sen Memorial Hospital,
First Affiliated Hospital of Guangzhou Medical University
ORCID:
0000-0001-9254-2330
Observed ORCID:
0000-0001-9254-2330
OpenAlex ID:
A5026211978
Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
2023
·
Meng Tao
, Jing Han
, et al.
·
Journal of Hepatocellular Carcinoma
·
24
PDF
SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression
2024
·
Zhenyu Zhou
, Zheng Chen
, et al.
·
Cancer Science
·
14
m 6 A‐Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism
2025
·
Juanyi Shi
, Sintim Mui
, et al.
·
Advanced Science
·
12
PDF
Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma
2024
·
Juanyi Shi
, Kai Wen
, et al.
·
Clinical & Translational Oncology
·
7
Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis
2023
·
Kai Wen
, Feng Yang
, et al.
·
Frontiers in Oncology
·
4
PDF
Multi-omics analysis identifies OSGEPL1 as an oncogene in hepatocellular carcinoma
2025
·
Sintim Mui
, Juanyi Shi
, et al.
·
Discover Oncology
·
2
Supplementary code for: Multi-omics Dissection of Causal Targets for Thyroid Cancer in Women of Reproductive Age: Single-Cell and Spatial Validation, Co-Expression Networks, Virtual Gene Knockout, and Drug Repositioning
2026
·
Mui, Sintim
·
Zenodo (CERN European Organization for Nuclear Research)
Show more works
View as search
Works count:
7
Citation count:
63
H-index:
4
I10-index:
3
Year
Topic
Type